Literature DB >> 31376071

Caught between a "Rho" and a hard place: are CCN1/CYR61 and CCN2/CTGF the arbiters of microvascular stiffness?

Brahim Chaqour1.   

Abstract

The extracellular matrix (ECM) is a deformable dynamic structure that dictates the behavior, function and integrity of blood vessels. The composition, density, chemistry and architecture of major globular and fibrillar proteins of the matrisome regulate the mechanical properties of the vasculature (i.e., stiffness/compliance). ECM proteins are linked via integrins to a protein adhesome directly connected to the actin cytoskeleton and various downstream signaling pathways that enable the cells to respond to external stimuli in a coordinated manner and maintain optimal tissue stiffness. However, cardiovascular risk factors such as diabetes, dyslipidemia, hypertension, ischemia and aging compromise the mechanical balance of the vascular wall. Stiffening of large blood vessels is associated with well-known qualitative and quantitative changes of fibrillar and fibrous macromolecules of the vascular matrisome. However, the mechanical properties of the thin-walled microvasculature are essentially defined by components of the subendothelial matrix. Cellular communication network (CCN) 1 and 2 proteins (aka Cyr61 and CTGF, respectively) of the CCN protein family localize in and act on the pericellular matrix of microvessels and constitute primary candidate markers and regulators of microvascular compliance. CCN1 and CCN2 bind various integrin and non-integrin receptors and initiate signaling pathways that regulate connective tissue remodeling and response to injury, the associated mechanoresponse of vascular cells, and the subsequent inflammatory response. The CCN1 and CCN2 genes are themselves responsive to mechanical stimuli in vascular cells, wherein mechanotransduction signaling converges into the common Rho GTPase pathway, which promotes actomyosin-based contractility and cellular stiffening. However, CCN1 and CCN2 each exhibit unique functional attributes in these processes. A better understanding of their synergistic or antagonistic effects on the maintenance (or loss) of microvascular compliance in physiological and pathological situations will assist more broadly based studies of their functional properties and translational value.

Entities:  

Keywords:  Angiogenesis; Cellular communication network; CCN1/CYR61; CCN2/CTGF; Extracellular matrix proteins; Rho GTPase; Stiffness

Year:  2019        PMID: 31376071      PMCID: PMC7176800          DOI: 10.1007/s12079-019-00529-3

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.782


  119 in total

Review 1.  NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues.

Authors:  B Perbal
Journal:  Mol Pathol       Date:  2001-04

Review 2.  Extra-cellular matrix in vascular networks.

Authors:  George Bou-Gharios; Markella Ponticos; Vineeth Rajkumar; David Abraham
Journal:  Cell Prolif       Date:  2004-06       Impact factor: 6.831

3.  Susceptibility to liver fibrosis in mice expressing a connective tissue growth factor transgene in hepatocytes.

Authors:  Zhenyue Tong; Ruju Chen; Daniel S Alt; Sherri Kemper; Bernard Perbal; David R Brigstock
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425

Review 4.  Mechanical regulation of the Cyr61/CCN1 and CTGF/CCN2 proteins.

Authors:  Brahim Chaqour; Margarete Goppelt-Struebe
Journal:  FEBS J       Date:  2006-07-19       Impact factor: 5.542

5.  The matri-cellular proteins 'cysteine-rich, angiogenic-inducer, 61' and 'connective tissue growth factor' are regulated in experimentally-induced sepsis with multiple organ dysfunction.

Authors:  Claus V B Hviid; Johanna Samulin Erdem; David Kunke; Shakil M Ahmed; Signe F Kjeldsen; Yun Yong Wang; Håvard Attramadal; Ansgar O Aasen
Journal:  Innate Immun       Date:  2012-02-14       Impact factor: 2.680

6.  Fibrillin-1 genotype is associated with aortic stiffness and disease severity in patients with coronary artery disease.

Authors:  Tanya L Medley; Timothy J Cole; Christoph D Gatzka; William Y S Wang; Anthony M Dart; Bronwyn A Kingwell
Journal:  Circulation       Date:  2002-02-19       Impact factor: 29.690

Review 7.  CCN proteins: multifunctional signalling regulators.

Authors:  Bernard Perbal
Journal:  Lancet       Date:  2004-01-03       Impact factor: 79.321

8.  Correlation of connective tissue growth factor with liver stiffness measured by transient elastography in biliary atresia.

Authors:  Sittisak Honsawek; Wanvisa Udomsinprasert; Chintana Chirathaworn; Wilai Anomasiri; Paisarn Vejchapipat; Yong Poovorawan
Journal:  Hepatol Res       Date:  2012-11-27       Impact factor: 4.288

9.  Accumulation of NH2-terminal fragment of connective tissue growth factor in the vitreous of patients with proliferative diabetic retinopathy.

Authors:  David R Hinton; Christine Spee; Shikun He; Stephen Weitz; William Usinger; Laurie LaBree; Noelynn Oliver; Jennifer I Lim
Journal:  Diabetes Care       Date:  2004-03       Impact factor: 19.112

10.  Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10.

Authors:  D M Bradham; A Igarashi; R L Potter; G R Grotendorst
Journal:  J Cell Biol       Date:  1991-09       Impact factor: 10.539

View more
  13 in total

1.  Et tu, CCN1….

Authors:  Andrew Leask
Journal:  J Cell Commun Signal       Date:  2020-09       Impact factor: 5.782

Review 2.  Conjunction junction, what's the function? CCN proteins as targets in fibrosis and cancers.

Authors:  Andrew Leask
Journal:  Am J Physiol Cell Physiol       Date:  2020-03-04       Impact factor: 4.249

Review 3.  The CCN2/CTGF interactome: an approach to understanding the versatility of CCN2/CTGF molecular activities.

Authors:  Viktor Zaykov; Brahim Chaqour
Journal:  J Cell Commun Signal       Date:  2021-10-06       Impact factor: 5.782

4.  G-quadruplexes Stabilization Upregulates CCN1 and Accelerates Aging in Cultured Cerebral Endothelial Cells.

Authors:  Brian Noh; Maria P Blasco-Conesa; Yun-Ju Lai; Bhanu Priya Ganesh; Akihiko Urayama; Ines Moreno-Gonzalez; Sean P Marrelli; Louise D McCullough; Jose Felix Moruno-Manchon
Journal:  Front Aging       Date:  2022-01-12

5.  Selective deletion of connective tissue growth factor attenuates experimentally-induced pulmonary fibrosis and pulmonary arterial hypertension.

Authors:  Angela Y Y Tam; Amy L Horwell; Sarah L Trinder; Korsa Khan; Shiwen Xu; Voon Ong; Christopher P Denton; Jill T Norman; Alan M Holmes; George Bou-Gharios; David J Abraham
Journal:  Int J Biochem Cell Biol       Date:  2021-03-01       Impact factor: 5.085

6.  Germline Mutation Enrichment in Pathways Controlling Endothelial Cell Homeostasis in Patients with Brain Arteriovenous Malformation: Implication for Molecular Diagnosis.

Authors:  Concetta Scimone; Francesca Granata; Marcello Longo; Enricomaria Mormina; Cristina Turiaco; Antonio A Caragliano; Luigi Donato; Antonina Sidoti; Rosalia D'Angelo
Journal:  Int J Mol Sci       Date:  2020-06-17       Impact factor: 5.923

Review 7.  Eyeing the Extracellular Matrix in Vascular Development and Microvascular Diseases and Bridging the Divide between Vascular Mechanics and Function.

Authors:  Brahim Chaqour; Charles Karrasch
Journal:  Int J Mol Sci       Date:  2020-05-15       Impact factor: 5.923

Review 8.  CCN2 (Cellular Communication Network factor 2) in the bone marrow microenvironment, normal and malignant hematopoiesis.

Authors:  Roos J Leguit; Reinier A P Raymakers; Konnie M Hebeda; Roel Goldschmeding
Journal:  J Cell Commun Signal       Date:  2021-01-11       Impact factor: 5.782

9.  Epigenetics and expression of key genes associated with cardiac fibrosis: NLRP3, MMP2, MMP9, CCN2/CTGF and AGT.

Authors:  Sruti Chandra; Kenneth C Ehrlich; Michelle Lacey; Carl Baribault; Melanie Ehrlich
Journal:  Epigenomics       Date:  2021-02-04       Impact factor: 4.778

10.  CCN-Based Therapeutic Peptides Modify Pancreatic Ductal Adenocarcinoma Microenvironment and Decrease Tumor Growth in Combination with Chemotherapy.

Authors:  Andrea Resovi; Patrizia Borsotti; Tommaso Ceruti; Alice Passoni; Massimo Zucchetti; Alexander Berndt; Bruce L Riser; Giulia Taraboletti; Dorina Belotti
Journal:  Cells       Date:  2020-04-13       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.